Comparison of Fine‐Needle Aspiration and Core Needle Biopsy for the Pre‐Operative Diagnosis of Canine and Feline Mammary Gland Tumours

2024-9-5

Auranofin Suppresses the Growth of Canine Mammary Tumour Cells and Induces Apoptosis via the <scp>PI3K</scp>/<scp>AKT</scp> Pathway

2024-9-2

Histologic, Phenotypic, and Molecular Characterization of Feline Hodgkin‐Like Lymphoma With Classical Reed‐Sternberg Cells

2024-8-30

Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the <scp>COX</scp>–Prostanoid Cascade

2024-8-23

Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience

2024-8-21

Macrophage Colony Stimulating Factor (M‐<scp>CSF</scp>) and Interleukin‐34 (<scp>IL</scp>‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment

2024-8-20

Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies

2024-8-20

Issue Information

2024-8-12

Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance

2024-8-12

Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the <scp>UBo pTNM</scp> System

2024-8-5

Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma

2024-8-1

Hotspot Exon 15 Mutations in <scp>BRAF</scp> Are Uncommon in Feline Tumours

2024-7-17

Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer

2024-7-16

Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma

2024-7-15

<scp>DNA</scp> Methylation and Its Effects on <scp><i>TRIM29</i></scp> Gene Expression in the Equine Sarcoid Tissue

2024-7-10

Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial

2024-6-18

Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma

2024-6-18

Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022)

2024-6-18

Electrochemotherapy in dogs and cats–A review

2024-6-12

One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas

2024-6-12

Distribution of Inflammatory Infiltrate in Feline Mammary Lesions: Relationship With Clinicopathological Features

2024-6-11

Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma

2024-6-4

Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma

2024-5-16

Issue Information

2024-5-9

Identification of hypoxia‐induced metabolism‐associated genes in canine tumours

2024-5-7

Characterization of the dissemination of canine cancer misinformation on <scp>YouTube</scp>

2024-4-28

Effective detection of <i>BRAF^V595E</i> mutation in canine urothelial and prostate carcinomas using immunohistochemistry

2024-4-24

Evaluation of clinical response and prognostic factors in canine multicentric lymphoma treated with first rescue therapy

2024-4-22

Retrospective evaluation of toceranib phosphate (Palladia) in the treatment of canine carcinomatosis and mesothelioma

2024-4-15

Alternating rabacfosadine and doxorubicin for treatment of naïve canine lymphoma

2024-4-14

Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages <scp>II–IV</scp> canine malignant mammary tumours

2024-4-10

Radiation toxicity grading after chemoradiotherapy of canine urinary tract carcinomas: Comparing <scp>VRTOG</scp> to <scp>VRTOG_v2.0</scp>

2024-3-27

Effects of trastuzumab emtansine on canine urothelial carcinoma cells in vitro and in vivo

2024-3-19

Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study

2024-3-15

The role of companion animal models in radiopharmaceutical development and translation

2024-3-5

Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma

2024-2-22

Expression of <scp>mPGES1</scp> and p16 in feline and human oral squamous cell carcinoma: A comparative oncology approach

2024-2-20

Feline high‐grade and large granular lymphocyte alimentary lymphomas treated with <scp>COP</scp>‐ or <scp>CHOP</scp>‐based chemotherapy: A multi‐centric retrospective study of 57 cases

2024-2-14

Issue Information

2024-2-11

Magnetic resonance and computed tomographic imaging characteristics and potential molecular mechanisms of feline meningioma associated calvarial hyperostosis

2024-2-8

A retrospective Italian Society of Veterinary Oncology (<scp>SIONCOV</scp>) study of 56 cats with appendicular osteosarcoma

2024-2-7

ESVONC abstracts

2024-2-1

Issue Information

2024-2-1

Author Index

2024-2-1

Editorial

2024-1-29

Plasma cell‐free <scp>DNA</scp> in canine lymphoma patients as a novel material for genotyping

2024-1-29